RightEye
PrivateLast Round
Debt
Mar 16, 2020
Total Funding Raised
$10.86M
Company Overview
RightEye is a health technology company that has developed an eye-tracking technology designed to measure visual performance and track health issues.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Medical AI, Sports Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RightEye Comparables
Compare RightEye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroSync | 84% | |
| EyeGuide, Inc. | 84% | |
| WIVI Vision | 82% | |
RightEye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 16, 2020 | ||||
| VC Round | Nov 13, 2018 | ||||
| Series A | Sep 11, 2017 | ||||
| Seed | Mar 17, 2016 | ||||
| Angel | May 14, 2013 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 237% MoM, reaching 14.5K.
- Mar 16, 2020
$1M debt round completed.
RightEye Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RightEye's valuation, stock price, and market status.